Development of IGF signaling antibody arrays for the identification of hepatocellular carcinoma biomarkers.
PURPOSE: Our objective was to develop a system to simultaneously and quantitatively measure the expression levels of the insulin-like growth factor (IGF) family proteins in numerous samples and to apply this approach to profile the IGF family proteins levels in cancer and adjacent tissues from patie...
Main Authors: | Qi Zhou, Ying-Qing Mao, Wei-Dong Jiang, Yun-Ru Chen, Ren-Yu Huang, Xiang-Bing Zhou, Ya-Feng Wang, Zhi Shi, Zhong-Sheng Wang, Ruo-Pan Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3469629?pdf=render |
Similar Items
-
Dried blood sample analysis by antibody array across the total testing process
by: Kelly Whittaker, et al.
Published: (2021-10-01) -
The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug Resistance
by: Mai-Huong Thi Ngo, et al.
Published: (2021-02-01) -
Identification of IGF2BP3 as an Adverse Prognostic Biomarker of Gliomas
by: Chao Sun, et al.
Published: (2021-10-01) -
Maintenance of stemness in oxaliplatin-resistant hepatocellular carcinoma is associated with increased autocrine of IGF1.
by: Yang Bu, et al.
Published: (2014-01-01) -
Liquid biopsy to identify biomarkers for immunotherapy in hepatocellular carcinoma
by: Huang Ao, et al.
Published: (2021-12-01)